Serum levels of FGF21 are elevated in obese humans [7], and this protein has been suggested as a potential biomarker of Metabolic syndrome (Mets) and Type 2 Diabetes Mellitus (T2DM) [8]. This evidence concerns the gene FGF21 and metabolic syndrome.